BCLS Acquisition Corp. (Nasdaq: BLSA) is a blank check company sponsored by Bain Capital Life Sciences Investors, LLC, the dedicated life sciences investment arm of Bain Capital. The SPAC completed its initial public offering in 2021 and focuses its acquisition search on the life sciences and healthcare sector, targeting opportunities in biopharmaceuticals, medical devices, diagnostics, and related areas. The company filed its annual report on Form 10-K with the SEC on March 28, 2022, covering the fiscal year ended December 31, 2021, during which it remained in the target-identification phase as a pre-combination vehicle. Visit SpacDesk and sign up for full data, filings, and deal-tracking coverage on BLSA and hundreds of other active SPACs.